SOX9 and gastric cancer: The in vivo models included patient-derived xenograft (PDX), the Tff1 knockout, and Cdk1 conditional knockout mouse models.<h4>Results</h4>Our study identified concurrent overexpression of CDK1 and SOX9 in gastric cancer patients.